Glycolipid Stimulation of Invariant NKT Cells Expands a Unique Tissue-Resident Population of Precursors to Mature NK Cells Endowed with Oncolytic and Antimetastatic Properties

被引:4
作者
Choi, Joshua [1 ]
Rudak, Patrick T. [1 ]
Lesage, Sylvie [2 ]
Haeryfar, S. M. Mansour [1 ,3 ,4 ,5 ]
机构
[1] Western Univ, Dept Microbiol & Immunol, Room SDRI 234,1151 Richmond St, London, ON N6A 5C1, Canada
[2] Univ Montreal, Maisonneuve Rosemontt Hosp, Dept Immunol Oncol, Res Ctr, Montreal, PQ H1T 2M4, Canada
[3] Western Univ, Dept Med, Div Clin Immunol & Allergy, London, ON N6A 5A5, Canada
[4] Western Univ, Dept Surg, Div Gen Surg, London, ON N6A 5A5, Canada
[5] Westcrn Univ, Ctr Human Immunol, London, ON N6A 5C1, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
KILLER DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; IN-VIVO REQUIRES; MHC CLASS-I; ALPHA-GALACTOSYLCERAMIDE; T-CELLS; IFN-GAMMA; ANTITUMOR-ACTIVITY; RECEPTOR EXPRESSION; HEPATIC METASTASIS;
D O I
10.4049/jimmunol.1900487
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invariant NKT (iNKT) cells are innate-like T lymphocytes that recognize and respond to glycolipid Ags such as alpha-galactosylceramide (alpha-GalCer). This unique property has been exploited in clinical trials for multiple malignancies. While investigating mouse iNKT cell responses to alpha-GalCer in vivo, we found a dramatically enlarged tissue-resident population surprisingly coexpressing select dendritic cell, NK cell, and B cell markers. Further phenotypic and functional analyses revealed the identity of this B220(+)CD11c(+)MHC class II(+)NK1.1(+) population as precursors to mature NK (pre-mNK) cells, which also expressed high levels of proliferation and tissue retention markers but diminished sphingosine-1-phosphate receptor 1, a receptor that facilitates tissue trafficking. Accordingly, FTY720, a sphingosine-1-phosphate receptor 1 antagonist, failed to prevent pre-mNK cells' intrahepatic accumulation. We found iNKT cell-driven expansion of pre-mNK cells to be dependent on IL-12 and IL-18. Although alpha-GalCer-transactivated pre-mNK cells lost their capacity to process a model tumor Ag, they selectively expressed granzyme A and directly lysed YAC-1 thymoma cells through granule exocytosis. They also contributed to beta 2 microglobulin-deficient target cell destruction in vivo. Therefore, alpha-GalCer treatment skewed pre-mNK cell responses away from an APC-like phenotype and toward killer cell-like functions. Finally, the ability of alpha-GalCer to reduce the pulmonary metastatic burden of B16-F10 mouse melanoma was partially reversed by in vivo depletion of pre-mNK cells. To our knowledge, our findings shed new light on iNKT cells' mechanism of action and glycolipid-based immunotherapies. Therefore, we introduce pre-mNK cells as a novel downstream effector cell type whose anticancer properties may have been overlooked in previous investigations.
引用
收藏
页码:1808 / 1819
页数:12
相关论文
共 65 条
[1]   Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720 [J].
Allende, ML ;
Sasaki, T ;
Kawai, H ;
Olivera, A ;
Mi, YD ;
van Echten-Deckert, G ;
Hajdu, R ;
Rosenbach, M ;
Keohane, CA ;
Mandala, S ;
Spiegel, S ;
Proia, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52487-52492
[2]   CD69 Suppresses Sphingosine 1-Phosophate Receptor-1 (S1P1) Function through Interaction with Membrane Helix 4 [J].
Bankovich, Alexander J. ;
Shiow, Lawrence R. ;
Cyster, Jason G. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (29) :22328-22337
[3]   Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells [J].
Blasius, Amanda L. ;
Barchet, Winfried ;
Cella, Marina ;
Colonna, Marco .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (11) :2561-2568
[4]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[5]   Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells [J].
Caminschi, Irina ;
Ahmet, Fatma ;
Heger, Klaus ;
Brady, Jason ;
Nutt, Stephen L. ;
Vremec, David ;
Pietersz, Suzanne ;
Lahoud, Mireille H. ;
Eld, Louis Schofi ;
Hansen, Diana S. ;
O'Keeffe, Meredith ;
Smyth, Mark J. ;
Bedoui, Sammy ;
Davey, Gayle M. ;
Villadangos, Jose A. ;
Heath, William R. ;
Shortman, Ken .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (11) :2579-2590
[6]   Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity [J].
Chan, CW ;
Crafton, E ;
Fan, HN ;
Flook, J ;
Yoshimura, K ;
Skarica, M ;
Brockstedt, D ;
Dubensky, TW ;
Stins, MF ;
Lanier, LL ;
Pardoll, DM ;
Housseau, F .
NATURE MEDICINE, 2006, 12 (02) :207-213
[7]   Phase I clinical trial combining imatinib mesylate and IL-2 HLA-DR+ NK cell levels correlate with disease outcome [J].
Chaput, Nathalie ;
Flament, Caroline ;
Locher, Clara ;
Desbois, Melanie ;
Rey, Annie ;
Rusakiewicz, Sylvie ;
Poirier-Colame, Vichnou ;
Pautier, Patricia ;
Le Cesne, Axel ;
Soria, Jean-Charles ;
Paci, Angelo ;
Rosenzwajg, Michelle ;
Klatzmann, David ;
Eggermont, Alexander ;
Robert, Caroline ;
Zitvogel, Laurence .
ONCOIMMUNOLOGY, 2013, 2 (02)
[8]  
Chiodoni C, 2001, EUR J IMMUNOL, V31, P3101, DOI 10.1002/1521-4141(2001010)31:10<3101::AID-IMMU3101>3.0.CO
[9]  
2-8
[10]   A potential role for CD69 in thymocyte emigration [J].
Feng, CG ;
Woodside, KJ ;
Vance, BA ;
El-Khoury, D ;
Canelles, M ;
Lee, J ;
Gress, R ;
Fowlkes, BJ ;
Shores, EW ;
Love, PE .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (06) :535-544